--- title: "WELLCELL HOLD fell about 11%, WELLCELL HOLD Group plans to sell 145 million shares of the company" type: "News" locale: "en" url: "https://longbridge.com/en/news/236177640.md" description: "WELLCELL HOLD's stock price fell by about 11%, currently reported at HKD 8.39, with a market capitalization of HKD 8.39 billion. WELLCELL HOLD Group plans to sell 145 million shares of the company on April 15, 2025, signing sales agreements with Mr. Shou Jian and Hengfeng International Holdings Limited, with a selling price of HKD 6 per share. After the sale, WELLCELL HOLD Group will no longer be the controlling shareholder, and the board believes that this move will not have a negative impact on the company's business and prospects" datetime: "2025-04-16T07:38:24.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/236177640.md) - [en](https://longbridge.com/en/news/236177640.md) - [zh-HK](https://longbridge.com/zh-HK/news/236177640.md) generator: "portal-rs" --- # WELLCELL HOLD fell about 11%, WELLCELL HOLD Group plans to sell 145 million shares of the company WELLCELL HOLD is currently down 10.93%, trading at HKD 8.39, with a transaction volume of HKD 30.93 million and a latest market capitalization of HKD 8.39 billion. WELLCELL HOLD announced that the company's board of directors received a notification from one of its controlling shareholders, WELLCELL HOLD Group Limited, that on April 15, 2025, WELLCELL HOLD Group has entered into two sale agreements to sell the company's ordinary shares at a par value of HKD 0.005 per share. Among them: the first sale agreement is entered into with Mr. Shou Jian, involving the sale of 45 million shares at a price of HKD 6 per share, and the second sale agreement is entered into with Hengfeng International Holdings Limited, involving the sale of 100 million shares at a price of HKD 6 per share. After the completion of Sale Item One and Sale Item Two, assuming there are no other changes in the equity structure and issued shares, WELLCELL HOLD Group will no longer be the controlling shareholder of the company. The board of directors believes that the sale will not adversely affect the group's business operations and future prospects ### Related Stocks - [02961.HK](https://longbridge.com/en/quote/02961.HK.md) - [02477.HK](https://longbridge.com/en/quote/02477.HK.md) ## Related News & Research - [Starknet: Scheduled unlock releases up to 127 million STRK - 15 Dec 2026](https://longbridge.com/en/news/306371387.md) - [OBSBOT stellt Tail 2 ADV und Tail Air 2 vor: Erweiterung der kreativen Freiheit für professionelle Produktionsteams und Kreative](https://longbridge.com/en/news/306372789.md) - [Persona Earns CEN/TS 18099 High Certification for Injection Attack Detection](https://longbridge.com/en/news/306371119.md) - [Redwood Materials found a very practical use for AI: Sorting old batteries](https://longbridge.com/en/news/306372090.md) - [ModuleMD Continues to Strengthen Its Position in Allergy EHR Innovation with a New Generation of AI-Powered Technology](https://longbridge.com/en/news/306373301.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**